Literature DB >> 23685131

Ferritin light chain interacts with PEN-2 and affects γ-secretase activity.

Xinxin Li1, Yiqian Liu, Qiuyang Zheng, Guorui Yao, Peng Cheng, Guojun Bu, Huaxi Xu, Yun-wu Zhang.   

Abstract

Alzheimer's disease (AD) is primarily caused by overproduction/deposition of β-amyloid (Aβ) in the brain. Dysregulation of iron in the brain also contributes to AD. Although iron affects β-amyloid precursor protein (APP) expression and Aβ deposition, detailed role of iron in AD requires further elucidation. Aβ is produced by sequential proteolytic cleavages of APP by β-secretase and γ-secretase. The γ-secretase complex comprises presenilins (PS1 or PS2), nicastrin, APH-1, and PEN-2. Herein, we find that PEN-2 can interact with ferritin light chain (FTL), an important component of the iron storage protein ferritin. In addition, we show that overexpression of FTL increases the protein levels of PEN-2 and PS1 amino-terminal fragment (NTF) and promotes γ-secretase activity for more production of Aβ and notch intracellular domain (NICD). Furthermore, iron treatments increase the levels of FTL, PEN-2 and PS1 NTF and promote γ-secretase-mediated NICD production. Moreover, downregulation of FTL decreases the levels of PEN-2 and PS1 NTF. Together, our results suggest that iron can increase γ-secretase activity through promoting the level of FTL that interacts with and stabilizes PEN-2, providing a new molecular link between iron, PEN-2/γ-secretase and Aβ generation in AD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AD; APP; Alzheimer's disease; Aβ; CTF; FTH; FTL; Ferritin light chain; HEK293 cells stably expressing human APP Swedish mutations; HEK293Swe; Iron; NICD; NTF; PEN-2; PS1 or PS2; amino-terminal fragment; carboxyl-terminal fragment; ferritin heavy chain; ferritin light chain; notch intracellular domain; presenilin 1 or 2; β-amyloid; β-amyloid precursor protein; γ-Secretase

Mesh:

Substances:

Year:  2013        PMID: 23685131      PMCID: PMC3724929          DOI: 10.1016/j.neulet.2013.05.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

1.  Membrane topology of gamma-secretase component PEN-2.

Authors:  Adam S Crystal; Vanessa A Morais; Theodore C Pierson; Donald S Pijak; Dan Carlin; Virginia M-Y Lee; Robert W Doms
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

Review 2.  Substrate specificity of gamma-secretase and other intramembrane proteases.

Authors:  A J Beel; C R Sanders
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

Review 3.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

4.  Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity.

Authors:  Pablo Muñoz; Alexis Humeres; Claudio Elgueta; Alfredo Kirkwood; Cecilia Hidalgo; Marco T Núñez
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 5.  Vascular oxidative stress in Alzheimer disease.

Authors:  Xiongwei Zhu; Mark A Smith; Kazuhiro Honda; Gjumrakch Aliev; Paula I Moreira; Akihiko Nunomura; Gemma Casadesus; Peggy L R Harris; Sandra L Siedlak; George Perry
Journal:  J Neurol Sci       Date:  2007-03-06       Impact factor: 3.181

Review 6.  The gamma-secretase complex: machinery for intramembrane proteolysis.

Authors:  Takeshi Iwatsubo
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

Review 7.  Iron: the Redox-active center of oxidative stress in Alzheimer disease.

Authors:  Rudy J Castellani; Paula I Moreira; Gang Liu; Jon Dobson; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Neurochem Res       Date:  2007-05-17       Impact factor: 3.996

Review 8.  Ferritins: a family of molecules for iron storage, antioxidation and more.

Authors:  Paolo Arosio; Rosaria Ingrassia; Patrizia Cavadini
Journal:  Biochim Biophys Acta       Date:  2008-09-26

9.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

Review 10.  APP processing in Alzheimer's disease.

Authors:  Yun-wu Zhang; Robert Thompson; Han Zhang; Huaxi Xu
Journal:  Mol Brain       Date:  2011-01-07       Impact factor: 4.041

View more
  12 in total

1.  Iron increases APP translation and amyloid-beta production in the retina.

Authors:  Lucie Y Guo; Oleg Alekseev; Yafeng Li; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2014-10-16       Impact factor: 3.467

Review 2.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

Review 3.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

4.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

5.  Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease.

Authors:  Priyanka S Radadiya; Mackenzie M Thornton; Rajni V Puri; Sireesha Yerrathota; Johnny Dinh-Phan; Brenda Magenheimer; Dharmalingam Subramaniam; Pamela V Tran; Hao Zhu; Subhashini Bolisetty; James P Calvet; Darren P Wallace; Madhulika Sharma
Journal:  JCI Insight       Date:  2021-03-30

6.  The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease.

Authors:  Animesh Alexander Raha; Radhika Anand Vaishnav; Robert Paul Friedland; Adrian Bomford; Ruma Raha-Chowdhury
Journal:  Acta Neuropathol Commun       Date:  2013-09-03       Impact factor: 7.801

7.  The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation.

Authors:  Jin Hu; Ting Lin; Yuehong Gao; Junyue Xu; Chao Jiang; Guanghui Wang; Guojun Bu; Huaxi Xu; Haifeng Chen; Yun-wu Zhang
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

Review 8.  Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.

Authors:  Andrew Gleason; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2020-10-27       Impact factor: 7.620

9.  A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.

Authors:  Yazeli E Cruz-Rivera; Jaileene Perez-Morales; Yaritza M Santiago; Valerie M Gonzalez; Luisa Morales; Mauricio Cabrera-Rios; Clara E Isaza
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Iron and Alzheimer's Disease: From Pathogenesis to Therapeutic Implications.

Authors:  Jun-Lin Liu; Yong-Gang Fan; Zheng-Sheng Yang; Zhan-You Wang; Chuang Guo
Journal:  Front Neurosci       Date:  2018-09-10       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.